Access to anti-retroviral drugs, male in Estonia

Estonia: Access to anti-retroviral drugs, male was 68.0% in 2022. ◆ Volatile

Latest (2022)
68.0%
Change on year
unchanged
World rank
73rd
of 141 countries
All-time high
70.0%
in 2019
All-time low
2.0%
in 2001
Years of data
23
2000–2022

Access to anti-retroviral drugs, male in Estonia, 2000–2022

0204060802000201120222000: 12 %2001: 2 %2002: 2 %2003: 2 %2004: 3 %2005: 6 %2006: 10 %2007: 15 %2008: 20 %2009: 25 %2010: 33 %2011: 38 %2012: 44 %2013: 46 %2014: 50 %2015: 58 %2016: 63 %2017: 66 %2018: 68 %2019: 70 %2020: 69 %2021: 68 %2022: 68 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Estonia is 68.0%, measured in 2022.

The figure is up 54.5% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Estonia peaked at 70.0% in 2019 and was at its lowest, 2.0%, in 2001.

That places Estonia 73rd out of 141 countries with data for 2022, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Estonia, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Estonia, 2000 to 2022.
Year % Change
2000 12.0%
2001 2.0% -83.3%
2002 2.0% +0.0%
2003 2.0% +0.0%
2004 3.0% +50.0%
2005 6.0% +100.0%
2006 10.0% +66.7%
2007 15.0% +50.0%
2008 20.0% +33.3%
2009 25.0% +25.0%
2010 33.0% +32.0%
2011 38.0% +15.2%
2012 44.0% +15.8%
2013 46.0% +4.5%
2014 50.0% +8.7%
2015 58.0% +16.0%
2016 63.0% +8.6%
2017 66.0% +4.8%
2018 68.0% +3.0%
2019 70.0% +2.9%
2020 69.0% -1.4%
2021 68.0% -1.4%
2022 68.0% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 9.7% 2.0% 25.0% 10
2010s 53.6% 33.0% 70.0% 10
2020s 68.3% 68.0% 69.0% 3

Countries ranked near Estonia

  1. 72 Côte d'Ivoire 69.0% compare
  2. 73 Algeria 68.0% compare
  3. 73 Burkina Faso 68.0% compare
  4. 73 Dominican Republic 68.0% compare
  5. 73 Greece 68.0% compare

See the full ranking of 160 places →

More gender data for Estonia

All data for Estonia →

Frequently asked questions

What is access to anti-retroviral drugs, male in Estonia?
Access to anti-retroviral drugs, male in Estonia was 68.0% in 2022, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Estonia?
The highest recorded value was 70.0% in 2019.
What is the lowest access to anti-retroviral drugs, male recorded in Estonia?
The lowest recorded value was 2.0% in 2001.
How does Estonia rank for access to anti-retroviral drugs, male?
Estonia ranks 73rd out of 141 countries with data for 2022.
Is access to anti-retroviral drugs, male rising or falling in Estonia?
Over the last ten years it is up 54.5%. The long-run trend across the full record is volatile.
Where does this Estonia data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Estonia. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/estonia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/estonia/">Access to anti-retroviral drugs, male in Estonia</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.